Related references
Note: Only part of the references are listed.The Lim1 oncogene as a new therapeutic target for metastatic human renal cell carcinoma
Merle Hamaidi et al.
ONCOGENE (2019)
Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma
Brian I. Rini et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma
Robert J. Motzer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Ex vivo organotypic culture system of precision-cut slices of human pancreatic ductal adenocarcinoma
Sougat Misra et al.
SCIENTIFIC REPORTS (2019)
Xenograft and organoid model systems in cancer research
Margit Bleijs et al.
EMBO JOURNAL (2019)
Tumor Microenvironment Dynamics in Clear-Cell Renal Cell Carcinoma
Lynda Vuong et al.
CANCER DISCOVERY (2019)
Patient-reported outcomes of patients with advanced renal cell carcinoma treated with nivolumab plus ipilimumab versus sunitinib (CheckMate 214): a randomised, phase 3 trial
David Cella et al.
LANCET ONCOLOGY (2019)
Multi-regional Sequencing Elucidates the Evolution of Clear Cell Renal Cell Carcinoma
Christopher J. Ricketts et al.
CELL (2018)
CD45 in human physiology and clinical medicine
Andreas Rheinlaender et al.
IMMUNOLOGY LETTERS (2018)
Biomarkers as drug development tools: discovery, validation, qualification and use
Virginia B. Kraus
NATURE REVIEWS RHEUMATOLOGY (2018)
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma
R. J. Motzer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Genetic, transcriptional and post-translational regulation of the programmed death protein ligand 1 in cancer: biology and clinical correlations
Ioannis Zerdes et al.
ONCOGENE (2018)
Combined inhibition of PI3K and Src kinases demonstrates synergistic therapeutic efficacy in clear-cell renal carcinoma
Roelants Caroline et al.
Oncotarget (2018)
Analyses of repeated failures in cancer therapy for solid tumors: poor tumor-selective drug delivery, low therapeutic efficacy and unsustainable costs
Hiroshi Maeda et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2018)
CANCER A precision approach to tumour treatment
Rodrigo Dienstmann et al.
NATURE (2017)
Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine
Chantal Pauli et al.
CANCER DISCOVERY (2017)
Long-lived pancreatic ductal adenocarcinoma slice cultures enable precise study of the immune microenvironment
Xiuyun Jiang et al.
ONCOIMMUNOLOGY (2017)
Protocols and characterization data for 2D, 3D, and slice-based tumor models from the PREDECT project
Ronald de Hoogt et al.
SCIENTIFIC DATA (2017)
Patient-Derived Xenograft Models of Non-Small Cell Lung Cancer and Their Potential Utility in Personalized Medicine
Katherine M. Morgan et al.
FRONTIERS IN ONCOLOGY (2017)
Tumor Organoids as a Pre-clinical Cancer Model for Drug Discovery
Fleur Weeber et al.
CELL CHEMICAL BIOLOGY (2017)
Immune checkpoint inhibitors in advanced renal cell carcinoma: experience to date and future directions
M. B. Atkins et al.
ANNALS OF ONCOLOGY (2017)
Targeting HIF2α in Clear-Cell Renal Cell Carcinoma
Christopher J. Ricketts et al.
CANCER CELL (2016)
A Landscape of Pharmacogenomic Interactions in Cancer
Francesco Iorio et al.
CELL (2016)
Establishment of a large panel of patient-derived preclinical models of human renal cell carcinoma
Herve Lang et al.
ONCOTARGET (2016)
Organotypic slice cultures of human gastric and esophagogastric junction cancer
Justus Koerfer et al.
CANCER MEDICINE (2016)
Human Organotypic Cultured Cardiac Slices: New Platform For High Throughput Preclinical Human Trials
C. Kang et al.
SCIENTIFIC REPORTS (2016)
Prospective Derivation of a Living Organoid Biobank of Colorectal Cancer Patients
Marc van de Wetering et al.
CELL (2015)
Three-Dimensional Cell Culture-Based Screening Identifies the Anthelmintic Drug Nitazoxanide as a Candidate for Treatment of Colorectal Cancer
Wojciech Senkowski et al.
MOLECULAR CANCER THERAPEUTICS (2015)
Predicting Cancer Drug Response: Advancing the DREAM
Russ B. Altman
CANCER DISCOVERY (2015)
PD-L1 and Survival in Solid Tumors: A Meta-Analysis
Pin Wu et al.
PLOS ONE (2015)
Slice cultures from head and neck squamous cell carcinoma: a novel test system for drug susceptibility and mechanisms of resistance
M. M. Gerlach et al.
BRITISH JOURNAL OF CANCER (2014)
The evolving role of cancer cell line-based screens to define the impact of cancer genomes on drug response
Mathew J. Garnett et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2014)
Organoid cultures for the analysis of cancer phenotypes
Norman Sachs et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2014)
PD-1 blockade induces responses by inhibiting adaptive immune resistance
Paul C. Tumeh et al.
NATURE (2014)
Using pancreas tissue slices for in situ studies of islet of Langerhans and acinar cell biology
Anja Marciniak et al.
NATURE PROTOCOLS (2014)
An Interactive Resource to Identify Cancer Genetic and Lineage Dependencies Targeted by Small Molecules
Amrita Basu et al.
CELL (2013)
Cerebral organoids model human brain development and microcephaly
Madeline A. Lancaster et al.
NATURE (2013)
Organotypic slice cultures of human glioblastoma reveal different susceptibilities to treatments
Felicitas Merz et al.
NEURO-ONCOLOGY (2013)
Hypoxia Pathways and Cellular Stress Activate Pancreatic Stellate Cells: Development of an Organotypic Culture Model of Thick Slices of Normal Human Pancreas
Vinciane Rebours et al.
PLOS ONE (2013)
Novel Agents and Approaches for Advanced Renal Cell Carcinoma
Robert Figlin et al.
JOURNAL OF UROLOGY (2012)
Systematic identification of genomic markers of drug sensitivity in cancer cells
Mathew J. Garnett et al.
NATURE (2012)
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Jordi Barretina et al.
NATURE (2012)
Preclinical Predictors of Anticancer Drug Efficacy: Critical Assessment with Emphasis on Whether Nanomolar Potency Should Be Required of Candidate Agents
C. C. Wong et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
Temsirolimus, an mTOR inhibitor, enhances anti-tumour effects of heat shock protein cancer vaccines
Y. Wang et al.
BRITISH JOURNAL OF CANCER (2011)
Lim1, an Embryonal Transcription Factor, Is Absent in Multicystic Renal Dysplasia, but Reactivated in Nephroblastomas
Barbara Guertl et al.
PATHOBIOLOGY (2011)
Analysis of Food and Drug Administration-Approved Anticancer Agents in the NCI60 Panel of Human Tumor Cell Lines
Susan L. Holbeck et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Preclinical model of organotypic culture for pharmacodynamic profiling of human tumors
Valentina Vaira et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
The von Hippel-Lindau tumour suppressor protein: O2 sensing and cancer
William G. Kaelin
NATURE REVIEWS CANCER (2008)
Specific activation of the different fibrogenic cells in rat cultured liver slices mimicking in vivo situations
Christelle Guyot et al.
VIRCHOWS ARCHIV (2007)
PD-1 is expressed by tumor-infiltrating immune cells and is associated with poor outcome for patients with renal cell carcinoma
R. Houston Thompson et al.
CLINICAL CANCER RESEARCH (2007)
The NCI60 human tumour cell line anticancer drug screen
Robert H. Shoemaker
NATURE REVIEWS CANCER (2006)
Mononuclear cell infiltration in clear-cell renal cell carcinoma independently predicts patient survival
W. Scott Webster et al.
CANCER (2006)
Costimulatory molecule B7-H1 on primary and metastatic clear cell renal cell carcinoma
RH Thompson et al.
CANCER (2005)
Modeling tissue-specific signaling and organ function in three dimensions
KL Schmeichel et al.
JOURNAL OF CELL SCIENCE (2003)
Use of CD45 gating in three and four-color flow cytometric immunophenotyping: Guideline from the national institute of allergy and infectious diseases, division of AIDS
CT Schnizlein-Bick et al.
CYTOMETRY (2002)
Share Paper
